Donor stem cell transplantation associated with survival benefit
Wednesday, June 10, 2009 - 01:56
in Health & Medicine
An analysis of previous studies indicates that allogeneic stem cell transplantation (SCT) (stem cells from a compatible donor) is associated with significant overall and relapse-free survival benefit among adult patients with intermediate- and poor-risk but not good-risk acute myeloid leukaemia in first complete remission, compared with nonallogeneic SCT therapies, according to an article in the 10 June issue of JAMA...
Read the whole article on Science Centric
More from Science Centric
Related
- Donor stem cell transplantation associated with survival benefit for patients with leukemiaTue, 9 Jun 2009, 16:45:18 EDT
- Study IDs benefit of donor SCT for adults with acute myeloid leukemiaTue, 9 Jun 2009, 16:45:12 EDT
- Left side grafting is procedure of choice for adult-to-adult living donor liver transplantationThu, 29 Oct 2009, 10:49:54 EDT
- Older liver donors not associated with negative outcomes in transplant recipients with hepatitis CTue, 22 Jul 2008, 11:42:37 EDT
- Gender matching aids long-term survival after heart transplantsWed, 12 Nov 2008, 11:38:09 EST